WO2006078320A3 - Methods for manufacturing delivery devices and devices thereof - Google Patents
Methods for manufacturing delivery devices and devices thereof Download PDFInfo
- Publication number
- WO2006078320A3 WO2006078320A3 PCT/US2005/027477 US2005027477W WO2006078320A3 WO 2006078320 A3 WO2006078320 A3 WO 2006078320A3 US 2005027477 W US2005027477 W US 2005027477W WO 2006078320 A3 WO2006078320 A3 WO 2006078320A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- devices
- methods
- manufacturing delivery
- manufacturing
- delivery devices
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/048—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES05856905T ES2432556T3 (en) | 2004-08-04 | 2005-08-03 | Methods for manufacturing supply devices and their devices |
EP05856905.4A EP1781264B1 (en) | 2004-08-04 | 2005-08-03 | Methods for manufacturing delivery devices and devices thereof |
AU2005325213A AU2005325213B2 (en) | 2004-08-04 | 2005-08-03 | Methods for manufacturing delivery devices and devices thereof |
CA2575988A CA2575988C (en) | 2004-08-04 | 2005-08-03 | Methods for manufacturing delivery devices and devices thereof |
HK07111739.6A HK1103362A1 (en) | 2004-08-04 | 2007-10-31 | Methods for manufacturing delivery devices and devices thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US59917404P | 2004-08-04 | 2004-08-04 | |
US60/599,174 | 2004-08-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006078320A2 WO2006078320A2 (en) | 2006-07-27 |
WO2006078320A3 true WO2006078320A3 (en) | 2006-10-19 |
Family
ID=36660844
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/027477 WO2006078320A2 (en) | 2004-08-04 | 2005-08-03 | Methods for manufacturing delivery devices and devices thereof |
Country Status (8)
Country | Link |
---|---|
US (2) | US8541028B2 (en) |
EP (2) | EP2594259A1 (en) |
AU (1) | AU2005325213B2 (en) |
CA (1) | CA2575988C (en) |
ES (1) | ES2432556T3 (en) |
HK (1) | HK1103362A1 (en) |
PT (1) | PT1781264E (en) |
WO (1) | WO2006078320A2 (en) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7285304B1 (en) * | 2003-06-25 | 2007-10-23 | Advanced Cardiovascular Systems, Inc. | Fluid treatment of a polymeric coating on an implantable medical device |
US7989018B2 (en) * | 2001-09-17 | 2011-08-02 | Advanced Cardiovascular Systems, Inc. | Fluid treatment of a polymeric coating on an implantable medical device |
CA2437639C (en) | 2003-08-11 | 2016-07-05 | Valera Pharmaceuticals, Inc. | Long term drug delivery devices with polyurethane based polymers and their manufacture |
US7858110B2 (en) | 2003-08-11 | 2010-12-28 | Endo Pharmaceuticals Solutions, Inc. | Long term drug delivery devices with polyurethane based polymers and their manufacture |
US8221778B2 (en) | 2005-01-12 | 2012-07-17 | The Trustees Of The University Of Pennsylvania | Drug-containing implants and methods of use thereof |
PT1781264E (en) | 2004-08-04 | 2013-10-16 | Evonik Corp | Methods for manufacturing delivery devices and devices thereof |
EP1909689A4 (en) * | 2005-07-18 | 2011-11-16 | Univ Pennsylvania | Drug-containing implants and methods of use thereof |
US20090041825A1 (en) * | 2006-02-10 | 2009-02-12 | Kotov Nicholas A | Cell culture well-plates having inverted colloidal crystal scaffolds |
US20100273667A1 (en) * | 2006-02-10 | 2010-10-28 | The Regents Of The University Of Michigan | Cell culture well-plates having inverted colloidal crystal scaffolds |
WO2008006083A2 (en) * | 2006-07-07 | 2008-01-10 | Surmodics, Inc. | Beaded wound spacer device |
US7794495B2 (en) * | 2006-07-17 | 2010-09-14 | Advanced Cardiovascular Systems, Inc. | Controlled degradation of stents |
EP1917971A1 (en) * | 2006-10-27 | 2008-05-07 | Société de Conseils de Recherches et d'Applications Scientifiques ( S.C.R.A.S.) | Substained release formulations comprising very low molecular weight polymers |
EP2131815A4 (en) * | 2007-03-22 | 2012-11-07 | Alkermes Inc | Coacervation process |
WO2008153997A1 (en) * | 2007-06-07 | 2008-12-18 | Brookwood Pharmaceuticals, Inc. | Reduced-mass, long-acting dosage forms |
US20080317865A1 (en) * | 2007-06-20 | 2008-12-25 | Alkermes, Inc. | Quench liquids and washing systems for production of microparticles |
US20090110713A1 (en) * | 2007-10-31 | 2009-04-30 | Florencia Lim | Biodegradable polymeric materials providing controlled release of hydrophobic drugs from implantable devices |
US8124601B2 (en) * | 2007-11-21 | 2012-02-28 | Bristol-Myers Squibb Company | Compounds for the treatment of Hepatitis C |
JP5502751B2 (en) | 2007-12-20 | 2014-05-28 | エボニック コーポレイション | Process for preparing microparticles with low residual solvent concentration |
US20090202609A1 (en) * | 2008-01-06 | 2009-08-13 | Keough Steven J | Medical device with coating composition |
ES2656131T3 (en) | 2008-03-27 | 2018-02-23 | Clinuvel Pharmaceuticals Limited | Vitiligo Therapy |
US20110244015A1 (en) * | 2008-09-30 | 2011-10-06 | Endo Pharmaceuticals Solutions Inc. | Implantable device for the delivery of octreotide and methods of use thereof |
JP2012504139A (en) * | 2008-09-30 | 2012-02-16 | エンド ファーマスーティカルズ ソリューションズ インコーポレイテッド. | Implantable device for delivery of histrelin and method of use thereof |
BRPI0919465A2 (en) | 2008-09-30 | 2015-12-01 | Endo Pharmaceuticals Solutions | implantable device for risperidone release and methods of use of risperidone |
US8822546B2 (en) | 2008-12-01 | 2014-09-02 | Medtronic, Inc. | Flowable pharmaceutical depot |
EP2246063A1 (en) * | 2009-04-29 | 2010-11-03 | Ipsen Pharma S.A.S. | Sustained release formulations comprising GnRH analogues |
KR20120102598A (en) | 2009-09-17 | 2012-09-18 | 에보닉 데구사 코포레이션 | Implant devices that differ by release profile and methods of making and using same |
KR20120102606A (en) * | 2009-09-22 | 2012-09-18 | 에보닉 데구사 코포레이션 | Implant devices for modulating bioactive agent release profiles |
WO2012003210A1 (en) | 2010-06-30 | 2012-01-05 | Surmodics Pharmaceuticals, Inc. | Implant processing methods for thermally labile and other bioactive agents and implants prepared from same |
PT2588079E (en) | 2010-06-30 | 2014-11-24 | Evonik Corp | Core-sheath implant device having an inner core lobe |
JP2015505707A (en) * | 2011-12-16 | 2015-02-26 | コンビネント・バイオメデイカル・システムズ・インコーポレーテツド | Vaginal drug administration device and manufacturing method |
CN104203295A (en) * | 2011-12-23 | 2014-12-10 | 丹格·广·斯文·勒 | A process for modifying the surface morphology of a medical device |
WO2014062839A1 (en) | 2012-10-16 | 2014-04-24 | Surmodics, Inc. | Wound packing device and methods |
US10201457B2 (en) | 2014-08-01 | 2019-02-12 | Surmodics, Inc. | Wound packing device with nanotextured surface |
CN108042855A (en) * | 2017-12-20 | 2018-05-18 | 江苏省健尔康医用敷料有限公司 | The preparation method of polylactic acid anti-adhesion film |
SG11202005949UA (en) | 2018-05-24 | 2020-07-29 | Celanese Eva Performance Polymers Corp | Implantable device for sustained release of a macromolecular drug compound |
EP3801462A4 (en) | 2018-05-24 | 2022-03-16 | Celanese EVA Performance Polymers LLC | Implantable device for sustained release of a macromolecular drug compound |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4450150A (en) * | 1973-05-17 | 1984-05-22 | Arthur D. Little, Inc. | Biodegradable, implantable drug delivery depots, and method for preparing and using the same |
US4612009A (en) * | 1984-06-19 | 1986-09-16 | Ceskoslovenska Akademie Ved | Biodegradable implant and a method for preparation thereof |
US5153002A (en) * | 1991-03-04 | 1992-10-06 | University Of Montreal | Biocompatible gradient controlled release implant |
WO1993017662A1 (en) * | 1992-03-02 | 1993-09-16 | Daratech Pty. Ltd. | Improved implants |
US20030161881A1 (en) * | 2001-12-18 | 2003-08-28 | Hansen Henrik Egesborg | Solid dose micro implant |
Family Cites Families (409)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2648609A (en) | 1949-01-21 | 1953-08-11 | Wisconsin Alumni Res Found | Method of applying coatings to edible tablets or the like |
NL251030A (en) | 1959-04-30 | |||
US3117027A (en) | 1960-01-08 | 1964-01-07 | Wisconsin Alumni Res Found | Apparatus for coating particles in a fluidized bed |
US3207824A (en) | 1962-06-22 | 1965-09-21 | Wisconsin Alumni Res Found | Process for preparing agglomerates |
US3196827A (en) | 1962-11-19 | 1965-07-27 | Wisconsin Alumni Res Found | Apparatus for the encapsulation of discrete particles |
US3253944A (en) | 1964-01-13 | 1966-05-31 | Wisconsin Alumni Res Found | Particle coating process |
US3241520A (en) | 1964-10-19 | 1966-03-22 | Wisconsin Alumni Res Found | Particle coating apparatus |
US4419340A (en) | 1969-03-24 | 1983-12-06 | University Of Delaware | Controlled release of anticancer agents from biodegradable polymers |
US4344431A (en) | 1969-03-24 | 1982-08-17 | University Of Delaware | Polymeric article for dispensing drugs |
US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
US4069307A (en) | 1970-10-01 | 1978-01-17 | Alza Corporation | Drug-delivery device comprising certain polymeric materials for controlled release of drug |
US4351337A (en) | 1973-05-17 | 1982-09-28 | Arthur D. Little, Inc. | Biodegradable, implantable drug delivery device, and process for preparing and using the same |
US3978203A (en) | 1974-07-12 | 1976-08-31 | Dynatech Corporation | Sustained release of pharmaceuticals from polyester matrices |
US4093709A (en) | 1975-01-28 | 1978-06-06 | Alza Corporation | Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates) |
US4134742A (en) | 1977-06-06 | 1979-01-16 | Envirogenic Systems Company | Gas separation membranes |
US4186189A (en) | 1977-09-28 | 1980-01-29 | Ethicon, Inc. | Absorbable pharmaceutical compositions based on poly(alkylene oxalates) |
US4249531A (en) | 1979-07-05 | 1981-02-10 | Alza Corporation | Bioerodible system for delivering drug manufactured from poly(carboxylic acid) |
US4346709A (en) | 1980-11-10 | 1982-08-31 | Alza Corporation | Drug delivery devices comprising erodible polymer and erosion rate modifier |
IE52535B1 (en) * | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
IN156886B (en) | 1981-08-22 | 1985-11-30 | Council Scient Ind Res | |
US5310559A (en) | 1982-09-01 | 1994-05-10 | Hercon Laboratories Corporation | Device for controlled release and delivery to mammalian tissue of pharmacologically active agents incorporating a rate controlling member which comprises an alkylene-alkyl acrylate copolymer |
CH661206A5 (en) | 1983-09-23 | 1987-07-15 | Debiopharm Sa | PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF HORMONDEPENDENT DISEASES. |
US4623588A (en) | 1984-02-06 | 1986-11-18 | Biotek, Inc. | Controlled release composite core coated microparticles |
US4568559A (en) | 1984-02-06 | 1986-02-04 | Biotek, Inc. | Composite core coated microparticles and process of preparing same |
US6309669B1 (en) | 1984-03-16 | 2001-10-30 | The United States Of America As Represented By The Secretary Of The Army | Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix |
US6217911B1 (en) | 1995-05-22 | 2001-04-17 | The United States Of America As Represented By The Secretary Of The Army | sustained release non-steroidal, anti-inflammatory and lidocaine PLGA microspheres |
US6410056B1 (en) | 1984-03-16 | 2002-06-25 | The United States Of America As Represented By The Secretary Of The Army | Chemotherapeutic treatment of bacterial infections with an antibiotic encapsulated within a biodegradable polymeric matrix |
US4657543A (en) | 1984-07-23 | 1987-04-14 | Massachusetts Institute Of Technology | Ultrasonically modulated polymeric devices for delivering compositions |
US4650665A (en) | 1985-02-08 | 1987-03-17 | Ethicon, Inc. | Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition |
US4863735A (en) | 1985-02-19 | 1989-09-05 | Massachusetts Institute Of Technology | Biodegradable polymeric drug delivery system with adjuvant activity |
US4720384A (en) | 1985-05-03 | 1988-01-19 | E. I. Du Pont De Nemours And Company | Manufacture of hollow fine tubular drug delivery systems |
DE3521684A1 (en) | 1985-06-18 | 1986-12-18 | Dr. Müller-Lierheim KG, Biologische Laboratorien, 8033 Planegg | METHOD FOR COATING POLYMERS |
US4976949A (en) | 1985-10-25 | 1990-12-11 | The University Of Michigan | Controlled release dosage form |
DE3542972A1 (en) | 1985-12-05 | 1987-06-11 | Merck Patent Gmbh | PHARMACADEPOT |
US4794001A (en) | 1986-03-04 | 1988-12-27 | American Home Products Corporation | Formulations providing three distinct releases |
IT1204294B (en) * | 1986-03-11 | 1989-03-01 | Gentili Ist Spa | METHOD OF MANUFACTURE OF GRANULARS SUITABLE FOR THE PRODUCTION OF COATED TABLETS, FOR ORAL USE, WITH CONTROLLED RELEASE |
EP0246795A3 (en) | 1986-05-20 | 1990-04-04 | Advanced Peptide Development Limited | Synthetic natriuretic peptides |
CA1257199A (en) | 1986-05-20 | 1989-07-11 | Paul Y. Wang | Preparation containing bioactive macromolecular substance for multi-months release in vivo |
US4832686A (en) | 1986-06-24 | 1989-05-23 | Anderson Mark E | Method for administering interleukin-2 |
US4839130A (en) | 1986-07-17 | 1989-06-13 | United States Surgical Corporation | Process of making an absorbable surgical device |
US5322691A (en) | 1986-10-02 | 1994-06-21 | Sohrab Darougar | Ocular insert with anchoring protrusions |
US4981696A (en) | 1986-12-22 | 1991-01-01 | E. I. Du Pont De Nemours And Company | Polylactide compositions |
CH668553A5 (en) | 1987-02-02 | 1989-01-13 | Mepha Ag | MEDICINAL PRODUCTS WITH DELAYED RELEASE OF THE ACTIVE SUBSTANCE. |
US4883666A (en) | 1987-04-29 | 1989-11-28 | Massachusetts Institute Of Technology | Controlled drug delivery system for treatment of neural disorders |
US5114719A (en) | 1987-04-29 | 1992-05-19 | Sabel Bernhard A | Extended drug delivery of small, water-soluble molecules |
US4792448A (en) | 1987-06-11 | 1988-12-20 | Pfizer Inc. | Generic zero order controlled drug delivery system |
US4952403A (en) | 1987-06-19 | 1990-08-28 | President And Fellows Of Harvard College | Implants for the promotion of healing of meniscal tissue |
US5013553A (en) | 1987-06-30 | 1991-05-07 | Vipont Pharmaceutical, Inc. | Drug delivery devices |
US4894231A (en) | 1987-07-28 | 1990-01-16 | Biomeasure, Inc. | Therapeutic agent delivery system |
US4897268A (en) | 1987-08-03 | 1990-01-30 | Southern Research Institute | Drug delivery system and method of making the same |
DE3879031T2 (en) | 1987-08-08 | 1993-06-24 | Akzo Nv | CONCEPTUAL IMPLANT. |
GB2209937B (en) | 1987-09-21 | 1991-07-03 | Depiopharm S A | Water insoluble polypeptides |
US5035891A (en) | 1987-10-05 | 1991-07-30 | Syntex (U.S.A.) Inc. | Controlled release subcutaneous implant |
US5187150A (en) | 1987-10-14 | 1993-02-16 | Debiopharm S.A. | Polyester-based composition for the controlled release of polypeptide medicinal substances |
US5120802A (en) | 1987-12-17 | 1992-06-09 | Allied-Signal Inc. | Polycarbonate-based block copolymers and devices |
US5152781A (en) | 1987-12-17 | 1992-10-06 | Allied-Signal Inc. | Medical devices fabricated from homopolymers and copolymers having recurring carbonate units |
US4898734A (en) | 1988-02-29 | 1990-02-06 | Massachusetts Institute Of Technology | Polymer composite for controlled release or membrane formation |
US4902515A (en) | 1988-04-28 | 1990-02-20 | E. I. Dupont De Nemours And Company | Polylactide compositions |
US5702716A (en) | 1988-10-03 | 1997-12-30 | Atrix Laboratories, Inc. | Polymeric compositions useful as controlled release implants |
US5633002A (en) | 1988-10-04 | 1997-05-27 | Boehringer Ingelheim Gmbh | Implantable, biodegradable system for releasing active substance |
US5034229A (en) | 1988-12-13 | 1991-07-23 | Alza Corporation | Dispenser for increasing feed conversion of hog |
US4975280A (en) | 1989-01-23 | 1990-12-04 | Ethyl Corporation | Bioerodable sustained release implants |
US5141748A (en) | 1989-02-17 | 1992-08-25 | Hoffmann-La Roche, Inc. | Implant drug delivery device |
US6419655B1 (en) | 1998-07-16 | 2002-07-16 | Gonex, Inc. | Method for controlling animal populations utilizing a sterilant projectile |
US5019400A (en) | 1989-05-01 | 1991-05-28 | Enzytech, Inc. | Very low temperature casting of controlled release microspheres |
DE69024953T3 (en) | 1989-05-04 | 2005-01-27 | Southern Research Institute, Birmingham | encapsulation |
US5178874A (en) | 1989-06-30 | 1993-01-12 | Smithkline Beechman Corporation | Intermittent release dosage form |
US5273752A (en) | 1989-07-18 | 1993-12-28 | Alza Corporation | Controlled release dispenser comprising beneficial agent |
CH679207A5 (en) | 1989-07-28 | 1992-01-15 | Debiopharm Sa | |
US5225205A (en) | 1989-07-28 | 1993-07-06 | Debiopharm S.A. | Pharmaceutical composition in the form of microparticles |
US5439688A (en) | 1989-07-28 | 1995-08-08 | Debio Recherche Pharmaceutique S.A. | Process for preparing a pharmaceutical composition |
MY107937A (en) | 1990-02-13 | 1996-06-29 | Takeda Chemical Industries Ltd | Prolonged release microcapsules. |
US5290494A (en) | 1990-03-05 | 1994-03-01 | Board Of Regents, The University Of Texas System | Process of making a resorbable implantation device |
US5668254A (en) | 1990-05-11 | 1997-09-16 | Romano Deghenghi | D-2-alkyl-tryptophan and peptides containing same |
US5872100A (en) | 1990-05-11 | 1999-02-16 | Deghenghi; Romano | Peptides containing D-2-Alkyl-Tryptophan |
GB9011767D0 (en) | 1990-05-25 | 1990-07-18 | Britannia Pharmaceuticals Ltd | Pharmaceutical compositions |
US5234693A (en) | 1990-07-11 | 1993-08-10 | Alza Corporation | Delivery device with a protective sleeve |
NZ239370A (en) | 1990-08-22 | 1994-04-27 | Merck & Co Inc | Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone |
US5164190A (en) | 1990-12-11 | 1992-11-17 | Theratech, Inc. | Subsaturated transdermal drug delivery device exhibiting enhanced drug flux |
WO1992011843A1 (en) | 1991-01-09 | 1992-07-23 | Alza Corporation | Bioerodible devices and compositions for diffusional release of agents |
US5340586A (en) | 1991-04-12 | 1994-08-23 | University Of Southern California | Methods and formulations for use in treating oophorectomized women |
ES2107537T3 (en) | 1991-04-25 | 1997-12-01 | Univ Brown Res Found | IMMUNO INSULATED BIOCOMPATIBLE VEHICLE IMPLANTABLE TO SUPPLY SELECTED THERAPEUTIC PRODUCTS. |
US5800829A (en) | 1991-04-25 | 1998-09-01 | Brown University Research Foundation | Methods for coextruding immunoisolatory implantable vehicles with a biocompatible jacket and a biocompatible matrix core |
US5486362A (en) | 1991-05-07 | 1996-01-23 | Dynagen, Inc. | Controlled, sustained release delivery system for treating drug dependency |
US5403595A (en) | 1991-05-07 | 1995-04-04 | Dynagen, Inc. | Controlled, sustained release delivery system for smoking cessation |
HU222501B1 (en) | 1991-06-28 | 2003-07-28 | Endorecherche Inc. | Controlled release pharmaceutical composition containing mpa or mga and process for its preparation |
CH683149A5 (en) | 1991-07-22 | 1994-01-31 | Debio Rech Pharma Sa | Process for the preparation of microspheres of a biodegradable polymeric material. |
AU2605592A (en) | 1991-10-15 | 1993-04-22 | Atrix Laboratories, Inc. | Polymeric compositions useful as controlled release implants |
DK0542364T3 (en) | 1991-11-13 | 1996-03-11 | Glaxo Canada | Controlled release device |
DK0615438T3 (en) | 1991-12-05 | 1996-11-11 | Mallinckrodt Veterinary Inc | A carbohydrate glass matrix for long-term release of a therapeutic agent |
US5876452A (en) | 1992-02-14 | 1999-03-02 | Board Of Regents, University Of Texas System | Biodegradable implant |
US6013853A (en) | 1992-02-14 | 2000-01-11 | The University Of Texas System | Continuous release polymeric implant carrier |
US5456679A (en) | 1992-02-18 | 1995-10-10 | Alza Corporation | Delivery devices with pulsatile effect |
US5573934A (en) | 1992-04-20 | 1996-11-12 | Board Of Regents, The University Of Texas System | Gels for encapsulation of biological materials |
US5912015A (en) | 1992-03-12 | 1999-06-15 | Alkermes Controlled Therapeutics, Inc. | Modulated release from biocompatible polymers |
US5656297A (en) | 1992-03-12 | 1997-08-12 | Alkermes Controlled Therapeutics, Incorporated | Modulated release from biocompatible polymers |
US5429822A (en) | 1992-03-13 | 1995-07-04 | Cambridge Scientific, Inc. | Biodegradable bursting release system |
GB9206504D0 (en) | 1992-03-25 | 1992-05-06 | Jevco Ltd | Heteromorphic sponges as wound implants |
MX9301821A (en) | 1992-03-30 | 1994-03-31 | Alza Corp | BIODEGRADABLE POLYMERICAL MATRIX SYSTEM DEGRADATION REGULATOR AND METHOD OF TREATMENT OF THE SAME. |
US5756117A (en) | 1992-04-08 | 1998-05-26 | International Medical Asscociates, Inc. | Multidose transdermal drug delivery system |
US5461140A (en) | 1992-04-30 | 1995-10-24 | Pharmaceutical Delivery Systems | Bioerodible polymers for solid controlled release pharmaceutical compositions |
US5518730A (en) | 1992-06-03 | 1996-05-21 | Fuisz Technologies Ltd. | Biodegradable controlled release flash flow melt-spun delivery system |
US5711968A (en) | 1994-07-25 | 1998-01-27 | Alkermes Controlled Therapeutics, Inc. | Composition and method for the controlled release of metal cation-stabilized interferon |
US5716644A (en) | 1992-06-11 | 1998-02-10 | Alkermes, Inc. | Composition for sustained release of non-aggregated erythropoietin |
US6514533B1 (en) | 1992-06-11 | 2003-02-04 | Alkermas Controlled Therapeutics, Inc. | Device for the sustained release of aggregation-stabilized, biologically active agent |
US5922340A (en) | 1992-09-10 | 1999-07-13 | Children's Medical Center Corporation | High load formulations and methods for providing prolonged local anesthesia |
FR2695826B1 (en) | 1992-09-21 | 1995-01-06 | Theramex | New pharmaceutical compositions based on nomegestrol derivatives and methods for obtaining them. |
GB9223144D0 (en) | 1992-11-05 | 1992-12-16 | Scherer Corp R P | Controlled release device |
ATE195652T1 (en) | 1992-12-02 | 2000-09-15 | Alkermes Inc | CONTROLLED RELEASE MICROSPHERES CONTAINING GROWTH HORMONE |
GB2273874A (en) | 1992-12-31 | 1994-07-06 | Pertti Olavi Toermaelae | Preparation of pharmaceuticals in a polymer matrix |
US5429634A (en) | 1993-09-09 | 1995-07-04 | Pdt Systems | Biogenic implant for drug delivery and method |
US6096331A (en) | 1993-02-22 | 2000-08-01 | Vivorx Pharmaceuticals, Inc. | Methods and compositions useful for administration of chemotherapeutic agents |
US6090925A (en) | 1993-03-09 | 2000-07-18 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
US5478355A (en) | 1993-03-18 | 1995-12-26 | United States Surgical Corporation | Method for improving the in vivo strength retention of a bioabsorbable implantable medical device and resulting medical device |
US5382435A (en) | 1993-03-24 | 1995-01-17 | Southwest Research Institute | Microparticulate pharmaceutical delivery system |
US5456917A (en) | 1993-04-12 | 1995-10-10 | Cambridge Scientific, Inc. | Method for making a bioerodible material for the sustained release of a medicament and the material made from the method |
ATE223493T1 (en) | 1993-04-21 | 2002-09-15 | Pasteur Institut | BIOCOMPATIBLE IMPLANT FOR IN VIVO EXPRESSION AND SECRETION OF THERAPEUTIC COMPOUND |
TW282403B (en) | 1993-08-26 | 1996-08-01 | Takeda Pharm Industry Co Ltd | |
IL110787A0 (en) | 1993-08-27 | 1994-11-11 | Sandoz Ag | Biodegradable polymer, its preparation and pharmaceutical composition containing it |
DE69426414T2 (en) | 1993-09-24 | 2001-05-03 | Takiron Co | IMPLANT MATERIAL |
US5681873A (en) | 1993-10-14 | 1997-10-28 | Atrix Laboratories, Inc. | Biodegradable polymeric composition |
US6913767B1 (en) | 1993-10-25 | 2005-07-05 | Genentech, Inc. | Compositions for microencapsulation of antigens for use as vaccines |
US5443505A (en) | 1993-11-15 | 1995-08-22 | Oculex Pharmaceuticals, Inc. | Biocompatible ocular implants |
JP3720386B2 (en) | 1993-12-27 | 2005-11-24 | 住友製薬株式会社 | Drug release controlled formulation |
US5554147A (en) | 1994-02-01 | 1996-09-10 | Caphco, Inc. | Compositions and devices for controlled release of active ingredients |
US5626611A (en) | 1994-02-10 | 1997-05-06 | United States Surgical Corporation | Composite bioabsorbable materials and surgical articles made therefrom |
EP0804249A2 (en) | 1994-03-15 | 1997-11-05 | Brown University Research Foundation | Polymeric gene delivery system |
JP4259610B2 (en) | 1994-04-08 | 2009-04-30 | キューエルティー・ユーエスエイ・インコーポレーテッド | Liquid delivery composition |
US6447796B1 (en) | 1994-05-16 | 2002-09-10 | The United States Of America As Represented By The Secretary Of The Army | Sustained release hydrophobic bioactive PLGA microspheres |
US6855331B2 (en) | 1994-05-16 | 2005-02-15 | The United States Of America As Represented By The Secretary Of The Army | Sustained release hydrophobic bioactive PLGA microspheres |
US5958458A (en) | 1994-06-15 | 1999-09-28 | Dumex-Alpharma A/S | Pharmaceutical multiple unit particulate formulation in the form of coated cores |
US5633000A (en) | 1994-06-23 | 1997-05-27 | Axxia Technologies | Subcutaneous implant |
US5817327A (en) | 1994-07-27 | 1998-10-06 | The Trustees Of The University Of Pennsylvania | Incorporation of biologically active molecules into bioactive glasses |
US5626862A (en) | 1994-08-02 | 1997-05-06 | Massachusetts Institute Of Technology | Controlled local delivery of chemotherapeutic agents for treating solid tumors |
US5681568A (en) | 1994-08-19 | 1997-10-28 | Cambridge Neuroscience, Inc. | Device for delivery of substances and methods of use thereof |
SK284550B6 (en) | 1994-09-27 | 2005-06-02 | Romano Deghenghi | Peptides, pharmaceutical composition containing them and their use |
AUPM897594A0 (en) | 1994-10-25 | 1994-11-17 | Daratech Pty Ltd | Controlled release container |
US6395303B1 (en) | 1996-06-10 | 2002-05-28 | Edward Mendell Co., Inc. | Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose |
DE69603577T2 (en) | 1995-02-10 | 1999-11-25 | Medtronic Inc | METHOD AND DEVICE FOR ADMINISTERING ANALGES |
US5900425A (en) | 1995-05-02 | 1999-05-04 | Bayer Aktiengesellschaft | Pharmaceutical preparations having controlled release of active compound and processes for their preparation |
US5922253A (en) | 1995-05-18 | 1999-07-13 | Alkermes Controlled Therapeutics, Inc. | Production scale method of forming microparticles |
US6902743B1 (en) | 1995-05-22 | 2005-06-07 | The United States Of America As Represented By The Secretary Of The Army | Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix |
US5869079A (en) | 1995-06-02 | 1999-02-09 | Oculex Pharmaceuticals, Inc. | Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
US6774278B1 (en) | 1995-06-07 | 2004-08-10 | Cook Incorporated | Coated implantable medical device |
ATE267587T1 (en) | 1995-06-09 | 2004-06-15 | Euro Celtique Sa | FORMULATIONS AND METHODS FOR PROLONGED LOCAL ANESTHESIA |
US6245347B1 (en) | 1995-07-28 | 2001-06-12 | Zars, Inc. | Methods and apparatus for improved administration of pharmaceutically active compounds |
US5705191A (en) | 1995-08-18 | 1998-01-06 | The United States Of America As Represented By The Secretary Of The Navy | Sustained delivery of active compounds from tubules, with rational control |
US6265389B1 (en) | 1995-08-31 | 2001-07-24 | Alkermes Controlled Therapeutics, Inc. | Microencapsulation and sustained release of oligonucleotides |
AU710347B2 (en) | 1995-08-31 | 1999-09-16 | Alkermes Controlled Therapeutics, Inc. | Composition for sustained release of an agent |
TW448055B (en) | 1995-09-04 | 2001-08-01 | Takeda Chemical Industries Ltd | Method of production of sustained-release preparation |
FI954565A0 (en) | 1995-09-27 | 1995-09-27 | Biocon Oy | Biologically applied polymeric material to the implant and foil preparation |
AUPN605795A0 (en) | 1995-10-19 | 1995-11-09 | F.H. Faulding & Co. Limited | Analgesic pharmaceutical composition |
US5965125A (en) | 1995-10-25 | 1999-10-12 | Transkaryotic Therapies, Inc. | Hybrid matrix implants and explants |
US6419920B1 (en) | 1995-10-25 | 2002-07-16 | Trans Karyotic Therapies, Inc. | Hybrid matrix implants and explants |
CZ293808B6 (en) | 1996-02-02 | 2004-08-18 | Alzaácorporation | Implantable device for delivering leuprolide to a fluid environment of use |
US6395292B2 (en) | 1996-02-02 | 2002-05-28 | Alza Corporation | Sustained delivery of an active agent using an implantable system |
US6156331A (en) | 1996-02-02 | 2000-12-05 | Alza Corporation | Sustained delivery of an active agent using an implantable system |
US6261584B1 (en) | 1996-02-02 | 2001-07-17 | Alza Corporation | Sustained delivery of an active agent using an implantable system |
DE19608423A1 (en) | 1996-03-05 | 1997-09-11 | Merck Patent Gmbh | Phased drug delivery implants |
US6299895B1 (en) | 1997-03-24 | 2001-10-09 | Neurotech S.A. | Device and method for treating ophthalmic diseases |
US5747060A (en) | 1996-03-26 | 1998-05-05 | Euro-Celtique, S.A. | Prolonged local anesthesia with colchicine |
FR2748205A1 (en) | 1996-05-06 | 1997-11-07 | Debio Rech Pharma Sa | PHARMACEUTICAL COMPOSITIONS FOR THE CONTROLLED RELEASE OF INSOLUBLE ACTIVE SUBSTANCES |
US5817343A (en) | 1996-05-14 | 1998-10-06 | Alkermes, Inc. | Method for fabricating polymer-based controlled-release devices |
DE19622355A1 (en) | 1996-06-04 | 1997-12-11 | Bayer Ag | Molded bodies that release agrochemicals |
US5807985A (en) | 1996-06-11 | 1998-09-15 | Deghenghi; Romano | Oligopeptide compounds containing D-2-alkyltryptophan capable of promoting the release of growth hormone |
US6066325A (en) | 1996-08-27 | 2000-05-23 | Fusion Medical Technologies, Inc. | Fragmented polymeric compositions and methods for their use |
US5945128A (en) | 1996-09-04 | 1999-08-31 | Romano Deghenghi | Process to manufacture implants containing bioactive peptides |
DE19701912C1 (en) | 1997-01-10 | 1998-05-14 | Jenapharm Gmbh | Implant for controlled drug release |
US6203813B1 (en) | 1997-01-13 | 2001-03-20 | Lance L. Gooberman | Pharmaceutical delivery device and method of preparation therefor |
FR2762318B1 (en) | 1997-04-18 | 1999-09-17 | Pharma Biotech | COMPOSITIONS HAVING SUSTAINED RELEASE AND A PROCESS FOR THEIR PREPARATION |
ES2285770T3 (en) | 1997-05-12 | 2007-11-16 | Metabolix, Inc. | POLYHYDROXIALCANOATE FOR LIVE APPLICATIONS. |
US5945284A (en) | 1997-05-27 | 1999-08-31 | The Perkin-Elmer Corporation | Length determination of nucleic acid repeat sequences by discontinuous primer extension |
US5874098A (en) | 1997-05-28 | 1999-02-23 | Ivy Laboratories, Inc. | Pellet implant system |
IL133105A (en) | 1997-06-04 | 2004-09-27 | Debio Rech Pharma Sa | Implants for controlled release of pharmaceutically active principles and method for making same |
SI9700186B (en) | 1997-07-14 | 2006-10-31 | Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. | Novel pharmaceutical preparation with controlled release of active healing substances |
JP2001510151A (en) | 1997-07-18 | 2001-07-31 | インファイムド,インク. | Biodegradable macromers for controlled release of bioactive substances |
US6828357B1 (en) | 1997-07-31 | 2004-12-07 | Metabolix, Inc. | Polyhydroxyalkanoate compositions having controlled degradation rates |
AU9062998A (en) | 1997-09-11 | 1999-03-29 | Nycomed Danmark A/S | Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (nsaids) |
US6120788A (en) | 1997-10-16 | 2000-09-19 | Bioamide, Inc. | Bioabsorbable triglycolic acid poly(ester-amide)s |
CA2221195A1 (en) | 1997-11-14 | 1999-05-14 | Chantal E. Holy | Biodegradable polymer matrix |
US6472210B1 (en) | 1997-11-14 | 2002-10-29 | Bonetec Corporation | Polymer scaffold having microporous polymer struts defining interconnected macropores |
US6187329B1 (en) | 1997-12-23 | 2001-02-13 | Board Of Regents Of The University Of Texas System | Variable permeability bone implants, methods for their preparation and use |
JP2003523308A (en) | 1998-03-02 | 2003-08-05 | アプライド ワクチン テクノロジーズ コーポレーション | Methods and devices for modulating an immune response |
ES2359973T3 (en) | 1998-03-19 | 2011-05-30 | MERCK SHARP & DOHME CORP. | LIQUID POLYMER COMPOSITIONS FOR THE CONTROLLED RELEASE OF BIOACTIVE SUBSTANCES. |
US6296831B1 (en) | 1998-04-10 | 2001-10-02 | Battelle Memorial Institute | Stimulus sensitive gel with radioisotope and methods of making |
US6406719B1 (en) | 1998-05-13 | 2002-06-18 | Microbiological Research Authority | Encapsulation of bioactive agents |
US6129757A (en) | 1998-05-18 | 2000-10-10 | Scimed Life Systems | Implantable members for receiving therapeutically useful compositions |
TW586944B (en) | 1998-05-29 | 2004-05-11 | Sumitomo Pharma | Controlled release agent having a multi-layer structure |
US6117441A (en) | 1998-07-02 | 2000-09-12 | The Population Council, Inc. | Silicone core long term androgen delivery implant |
IL140899A0 (en) | 1998-07-17 | 2002-02-10 | Skyepharma Inc | Lipid/polymer containing pharmaceutical compositions and processes for the preparation thereof |
US6641831B1 (en) | 1998-08-06 | 2003-11-04 | Schierholz Joerg | Medical products with sustained pharmacological activity and process for producing them |
US20040126404A1 (en) | 1998-08-21 | 2004-07-01 | University Of Queensland Of St. Lucia | Implant material |
US6335029B1 (en) | 1998-08-28 | 2002-01-01 | Scimed Life Systems, Inc. | Polymeric coatings for controlled delivery of active agents |
EP1112043B1 (en) | 1998-09-10 | 2006-04-05 | Percardia, Inc. | Tmr shunt |
US6143314A (en) | 1998-10-28 | 2000-11-07 | Atrix Laboratories, Inc. | Controlled release liquid delivery compositions with low initial drug burst |
US6565874B1 (en) | 1998-10-28 | 2003-05-20 | Atrix Laboratories | Polymeric delivery formulations of leuprolide with improved efficacy |
US6063395A (en) | 1998-11-12 | 2000-05-16 | Leiras Oy | Drug delivery device especially for the delivery of progestins and estrogens |
US6117442A (en) | 1998-11-12 | 2000-09-12 | Leiras Oy | Drug delivery device, especially for the delivery of androgens |
US6165486A (en) | 1998-11-19 | 2000-12-26 | Carnegie Mellon University | Biocompatible compositions and methods of using same |
IT1304152B1 (en) | 1998-12-10 | 2001-03-08 | Mediolanum Farmaceutici Srl | COMPOSITIONS INCLUDING A PEPTIDE AND POLYLACTIC-GLYCOLIC ACID FOR THE PREPARATION OF SUBCUTANEOUS IMPLANTS HAVING A PROLONGED |
US6692520B1 (en) | 1998-12-15 | 2004-02-17 | C. R. Bard, Inc. | Systems and methods for imbedded intramuscular implants |
US6455526B1 (en) | 1998-12-16 | 2002-09-24 | Aventis Pharmaceuticals, Inc. | Biodegradable polymer encapsulated pharmaceutical compositions and method for preparing the same |
US6696073B2 (en) | 1999-02-23 | 2004-02-24 | Osteotech, Inc. | Shaped load-bearing osteoimplant and methods of making same |
US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
US6835194B2 (en) | 1999-03-18 | 2004-12-28 | Durect Corporation | Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners |
DE60026513T2 (en) | 1999-05-27 | 2006-10-05 | Biocompatibles Uk Ltd., Farnham | LOCAL DRUG DELIVERY |
US6541020B1 (en) | 1999-07-09 | 2003-04-01 | Trimeris, Inc. | Methods and compositions for administration of therapeutic reagents |
US6309660B1 (en) | 1999-07-28 | 2001-10-30 | Edwards Lifesciences Corp. | Universal biocompatible coating platform for medical devices |
US6855160B1 (en) | 1999-08-04 | 2005-02-15 | C. R. Bard, Inc. | Implant and agent delivery device |
CN1378445B (en) | 1999-08-06 | 2013-02-06 | 得克萨斯系统大学评议会 | Drug releasing biodegradable fiber implant |
FI19991852A (en) | 1999-09-01 | 2001-03-01 | Yli Urpo Antti | New multilayer material with a biologically active agent, and its preparation |
JP4172883B2 (en) | 1999-09-08 | 2008-10-29 | Hoya株式会社 | Drug sustained release carrier and method for producing drug sustained release carrier |
US6573311B1 (en) | 1999-09-22 | 2003-06-03 | Atrium Medical Corporation | Method for treating polymer materials and products produced therefrom |
US6331313B1 (en) | 1999-10-22 | 2001-12-18 | Oculex Pharmaceticals, Inc. | Controlled-release biocompatible ocular drug delivery implant devices and methods |
US6461631B1 (en) | 1999-11-16 | 2002-10-08 | Atrix Laboratories, Inc. | Biodegradable polymer composition |
US6579533B1 (en) | 1999-11-30 | 2003-06-17 | Bioasborbable Concepts, Ltd. | Bioabsorbable drug delivery system for local treatment and prevention of infections |
US20040009228A1 (en) | 1999-11-30 | 2004-01-15 | Pertti Tormala | Bioabsorbable drug delivery system for local treatment and prevention of infections |
US20020131988A1 (en) | 1999-12-16 | 2002-09-19 | Foster Todd P. | Pharmaceutical implant containing immediate-release and sustained-release components and method of administration |
CN1404388A (en) | 2000-01-20 | 2003-03-19 | 德尔西斯药品公司 | Multi-step drug dosage forms |
TWI284048B (en) | 2000-01-27 | 2007-07-21 | Zentaris Ag | Compressed microparticles for dry injection |
JP5154726B2 (en) | 2000-02-17 | 2013-02-27 | ネオメンド,インコーポレイティド | Delivery system and method using preformed biodegradable polymer composition |
US20040208910A1 (en) | 2000-04-26 | 2004-10-21 | Control Delivery Systems, Inc. | Sustained release device and method for ocular delivery of adrenergic agents |
US6375972B1 (en) | 2000-04-26 | 2002-04-23 | Control Delivery Systems, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
US20040175410A1 (en) | 2000-04-26 | 2004-09-09 | Control Delivery Systems, Inc. | Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors |
US7300662B2 (en) | 2000-05-12 | 2007-11-27 | Cordis Corporation | Drug/drug delivery systems for the prevention and treatment of vascular disease |
US20040243097A1 (en) | 2000-05-12 | 2004-12-02 | Robert Falotico | Antiproliferative drug and delivery device |
US20050002986A1 (en) | 2000-05-12 | 2005-01-06 | Robert Falotico | Drug/drug delivery systems for the prevention and treatment of vascular disease |
US6419954B1 (en) | 2000-05-19 | 2002-07-16 | Yamanouchi Pharmaceutical Co., Ltd. | Tablets and methods for modified release of hydrophilic and other active agents |
US6306423B1 (en) | 2000-06-02 | 2001-10-23 | Allergan Sales, Inc. | Neurotoxin implant |
KR100392501B1 (en) | 2000-06-28 | 2003-07-22 | 동국제약 주식회사 | Preparation Method for Sustained Release Microparticles by Multiple Emulsion Method and Micropartic les Thereof |
US6767550B1 (en) | 2000-06-30 | 2004-07-27 | Berkeley Advanced Biomaterials, Inc. | Hydroxyapatite based drug delivery implant for cancer treatment |
US8158143B2 (en) | 2000-07-14 | 2012-04-17 | Helmholtz-Zentrum Geesthacht Zentrum Fuer Material- Und Kuestenforschung Gmbh | Systems for releasing active ingredients, based on biodegradable or biocompatible polymers with a shape memory effect |
US6669959B1 (en) | 2000-07-18 | 2003-12-30 | Aeropharm Technology Incorporated | Modulated release particles for lung delivery |
US6479065B2 (en) | 2000-08-10 | 2002-11-12 | Alkermes Controlled Therapeutics, Inc. | Process for the preparation of polymer-based sustained release compositions |
US6296842B1 (en) | 2000-08-10 | 2001-10-02 | Alkermes Controlled Therapeutics, Inc. | Process for the preparation of polymer-based sustained release compositions |
DE10044545A1 (en) | 2000-09-05 | 2002-04-04 | Roland Bodmeier | Retardpartikeldispersion |
US6953560B1 (en) | 2000-09-28 | 2005-10-11 | Advanced Cardiovascular Systems, Inc. | Barriers for polymer-coated implantable medical devices and methods for making the same |
AU2001296770A1 (en) | 2000-10-06 | 2002-04-15 | Durect Corporation | Devices and methods for management of inflammation |
US6783793B1 (en) | 2000-10-26 | 2004-08-31 | Advanced Cardiovascular Systems, Inc. | Selective coating of medical devices |
US6746661B2 (en) | 2000-11-16 | 2004-06-08 | Microspherix Llc | Brachytherapy seed |
US6545097B2 (en) | 2000-12-12 | 2003-04-08 | Scimed Life Systems, Inc. | Drug delivery compositions and medical devices containing block copolymer |
US20030049320A1 (en) | 2000-12-18 | 2003-03-13 | Wockhardt Limited | Novel in-situ forming controlled release microcarrier delivery system |
US7192604B2 (en) | 2000-12-22 | 2007-03-20 | Ethicon, Inc. | Implantable biodegradable devices for musculoskeletal repair or regeneration |
US20020119179A1 (en) | 2000-12-22 | 2002-08-29 | Alireza Rezania | Implantable biodegradable devices for musculoskeletal repair or regeneration |
US6939375B2 (en) | 2000-12-22 | 2005-09-06 | Avantac Vascular Corporation | Apparatus and methods for controlled substance delivery from implanted prostheses |
WO2002056863A2 (en) | 2000-12-29 | 2002-07-25 | Bausch & Lomb Incorporated | Sustained release drug delivery devices |
EP1347741B1 (en) | 2001-01-03 | 2009-01-21 | Bausch & Lomb Incorporated | Sustained release drug delivery devices with multiple agents |
US6719935B2 (en) | 2001-01-05 | 2004-04-13 | Howmedica Osteonics Corp. | Process for forming bioabsorbable implants |
US6524615B2 (en) | 2001-02-21 | 2003-02-25 | Kos Pharmaceuticals, Incorporated | Controlled release pharmaceutical composition |
US20020131953A1 (en) | 2001-03-14 | 2002-09-19 | Ut Southwestern Medical Center | In situ langerhans cell vaccine |
DE10114244A1 (en) | 2001-03-22 | 2002-10-02 | Heraeus Kulzer Gmbh & Co Kg | Antibiotic / antibiotic preparation with active ingredient release |
DE10114247A1 (en) | 2001-03-22 | 2002-10-10 | Heraeus Kulzer Gmbh & Co Kg | Antibiotic / antibiotics-polymer combination |
EP1247537A1 (en) | 2001-04-04 | 2002-10-09 | Isotis B.V. | Coating for medical devices |
US6913762B2 (en) | 2001-04-25 | 2005-07-05 | Mayo Foundation For Medical Education And Research | Stent having non-woven framework containing cells |
US20020168393A1 (en) | 2001-05-08 | 2002-11-14 | Ryota Sugimoto | Implantable medical material and implantable medical device |
JP2004535431A (en) | 2001-06-22 | 2004-11-25 | サザン バイオシステムズ, インコーポレイテッド | Zero-order long-term release coaxial implant |
US6648849B2 (en) | 2001-06-27 | 2003-11-18 | Ethicon, Inc. | Medicinal implant and device and method for loading and delivering implants containing drugs and cells |
ES2385030T3 (en) | 2001-06-29 | 2012-07-17 | Medgraft Microtech, Inc. | Biodegradable injectable implants and procedures related to their manufacture and use |
AUPR602401A0 (en) | 2001-06-29 | 2001-07-26 | Smart Drug Systems Inc | Sustained release delivery system |
AUPR602501A0 (en) | 2001-06-29 | 2001-07-26 | Smart Drug Systems Inc | Sustained release pharmaceutical composition |
US6921390B2 (en) | 2001-07-23 | 2005-07-26 | Boston Scientific Scimed, Inc. | Long-term indwelling medical devices containing slow-releasing antimicrobial agents and having a surfactant surface |
US6913760B2 (en) | 2001-08-06 | 2005-07-05 | New England Medical Hospitals, Inc. | Drug delivery composition |
US7056338B2 (en) | 2003-03-28 | 2006-06-06 | Conor Medsystems, Inc. | Therapeutic agent delivery device with controlled therapeutic agent release rates |
US6669955B2 (en) | 2001-08-28 | 2003-12-30 | Longwood Pharmaceutical Research, Inc. | Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin |
US20040234572A1 (en) | 2001-09-11 | 2004-11-25 | Martinod Serge R. | Preparation of sustained release pharmaceutical composition |
GB2379390B (en) | 2001-09-11 | 2005-01-26 | Caretek Medical Ltd | A novel drug delivery technology |
GB0122113D0 (en) | 2001-09-11 | 2001-10-31 | Astrazeneca Ab | Composition |
US20050129728A1 (en) | 2001-09-11 | 2005-06-16 | Martinod Serge R. | Sustained release pharmaceutical composition |
US20030229390A1 (en) | 2001-09-17 | 2003-12-11 | Control Delivery Systems, Inc. | On-stent delivery of pyrimidines and purine analogs |
US7285304B1 (en) * | 2003-06-25 | 2007-10-23 | Advanced Cardiovascular Systems, Inc. | Fluid treatment of a polymeric coating on an implantable medical device |
IN2014DN10834A (en) | 2001-09-17 | 2015-09-04 | Psivida Inc | |
US20030158598A1 (en) | 2001-09-17 | 2003-08-21 | Control Delivery Systems, Inc. | System for sustained-release delivery of anti-inflammatory agents from a coated medical device |
US6827737B2 (en) | 2001-09-25 | 2004-12-07 | Scimed Life Systems, Inc. | EPTFE covering for endovascular prostheses and method of manufacture |
US7163691B2 (en) | 2001-10-12 | 2007-01-16 | Osteotech, Inc. | Bone graft |
US6926903B2 (en) | 2001-12-04 | 2005-08-09 | Inion Ltd. | Resorbable polymer composition, implant and method of making implant |
CA2822457C (en) | 2001-12-14 | 2016-03-08 | The University Of Wyoming | Methods and compositions for controlled resease of drugs |
GB2399753B (en) | 2002-01-18 | 2006-04-19 | Michael E Snyder | Method of making a sustained release ophthalmological device |
BR0307218A (en) | 2002-01-24 | 2004-12-07 | Smart Drug Systems Inc | Extended Release Pharmaceutical Composition |
US6887270B2 (en) | 2002-02-08 | 2005-05-03 | Boston Scientific Scimed, Inc. | Implantable or insertable medical device resistant to microbial growth and biofilm formation |
US8133501B2 (en) | 2002-02-08 | 2012-03-13 | Boston Scientific Scimed, Inc. | Implantable or insertable medical devices for controlled drug delivery |
DE10208335A1 (en) | 2002-02-27 | 2003-09-04 | Roehm Gmbh | Pharmaceutical form and process for its preparation |
US7074426B2 (en) | 2002-03-27 | 2006-07-11 | Frank Kochinke | Methods and drug delivery systems for the treatment of orofacial diseases |
US7101394B2 (en) | 2002-05-02 | 2006-09-05 | Boston Scientific Scimed, Inc. | Energetically-controlled delivery of biologically active material from an implanted medical device |
PT2561860T (en) | 2002-05-31 | 2018-05-08 | Titan Pharmaceuticals Inc | Implantable polymeric device for sustained release of buprenorphine |
NZ519363A (en) | 2002-06-05 | 2004-02-27 | Agres Ltd | A novel drug dosing regimen |
US7097850B2 (en) | 2002-06-18 | 2006-08-29 | Surmodics, Inc. | Bioactive agent release coating and controlled humidity method |
US7105175B2 (en) | 2002-06-19 | 2006-09-12 | Boston Scientific Scimed, Inc. | Implantable or insertable medical devices for controlled delivery of a therapeutic agent |
US7101566B2 (en) | 2002-06-28 | 2006-09-05 | Ethicon, Inc. | Polymer coated microparticles for sustained release |
US20040006146A1 (en) | 2002-07-06 | 2004-01-08 | Evans Douglas G. | Resorbable structure for treating and healing of tissue defects |
US7049348B2 (en) | 2002-07-06 | 2006-05-23 | Kensey Nash Corporation | Resorbable structure for treating and healing of tissue defects |
US6916483B2 (en) | 2002-07-22 | 2005-07-12 | Biodynamics, Llc | Bioabsorbable plugs containing drugs |
EP1545389B1 (en) | 2002-07-31 | 2020-04-22 | Mast Biosurgery AG | Apparatus for preventing adhesions between an implant and surrounding tissues |
AU2003258209A1 (en) | 2002-08-13 | 2004-02-25 | Medtronic, Inc. | Active agent delivery systems, medical devices, and methods |
US7951392B2 (en) | 2002-08-16 | 2011-05-31 | Boston Scientific Scimed, Inc. | Microarray drug delivery coatings |
US7438925B2 (en) | 2002-08-26 | 2008-10-21 | Biovention Holdings Ltd. | Drug eluting coatings for medical implants |
WO2004021861A2 (en) | 2002-09-03 | 2004-03-18 | Vit Lauermann | Targeted release |
DE10242476B4 (en) | 2002-09-11 | 2006-10-26 | Heraeus Kulzer Gmbh | Antibiotic / antibiotics-polymer combination |
US7459169B2 (en) | 2002-10-21 | 2008-12-02 | Allvivo, Inc. | Surface coating comprising bioactive compound |
MXPA05004927A (en) | 2002-11-06 | 2005-09-08 | Alza Corp | Controlled release depot formulations. |
US20050070989A1 (en) | 2002-11-13 | 2005-03-31 | Whye-Kei Lye | Medical devices having porous layers and methods for making the same |
US20060121080A1 (en) | 2002-11-13 | 2006-06-08 | Lye Whye K | Medical devices having nanoporous layers and methods for making the same |
US7758881B2 (en) | 2004-06-30 | 2010-07-20 | Advanced Cardiovascular Systems, Inc. | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device |
US20040143221A1 (en) | 2002-12-27 | 2004-07-22 | Shadduck John H. | Biomedical implant for sustained agent release |
EP1581270A2 (en) * | 2002-12-30 | 2005-10-05 | Angiotech International Ag | Silk-containing stent graft |
US7985414B2 (en) | 2003-02-04 | 2011-07-26 | Warsaw Orthopedic, Inc. | Polyurethanes for osteoimplants |
US20050079199A1 (en) | 2003-02-18 | 2005-04-14 | Medtronic, Inc. | Porous coatings for drug release from medical devices |
US20080051866A1 (en) | 2003-02-26 | 2008-02-28 | Chao Chin Chen | Drug delivery devices and methods |
US20060083767A1 (en) | 2003-02-27 | 2006-04-20 | Kai Deusch | Surgical prosthesis having biodegradable and nonbiodegradable regions |
GB0304726D0 (en) | 2003-03-01 | 2003-04-02 | Ardana Bioscience Ltd | New Process |
US8313759B2 (en) | 2003-03-06 | 2012-11-20 | Boston Scientific Scimed, Inc. | Implantable or insertable medical devices containing miscible polymer blends for controlled delivery of a therapeutic agent |
KR20060023111A (en) | 2003-03-14 | 2006-03-13 | 데비오 레쉑쉐 빠르마슈띠끄 에스.아 | Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders |
ZA200507877B (en) | 2003-03-31 | 2007-01-31 | Titan Pharmaceuticals Inc | Implantable polymeric device for sustained release of dopamine agonist |
WO2004087797A1 (en) | 2003-04-03 | 2004-10-14 | Corporation De L'ecole Polytechnique De Montreal | Microporous articles comprising biodegradable medical polymers, method of preparation thereof and method of use thereof |
US7241455B2 (en) | 2003-04-08 | 2007-07-10 | Boston Scientific Scimed, Inc. | Implantable or insertable medical devices containing radiation-crosslinked polymer for controlled delivery of a therapeutic agent |
US20060105018A1 (en) | 2004-11-17 | 2006-05-18 | Epstein Samuel J | Therapeutic driving layer for a medical device |
EP1633320A2 (en) | 2003-05-02 | 2006-03-15 | SurModics, Inc. | Implantable controlled release bioactive agent delivery device |
US20040224000A1 (en) | 2003-05-05 | 2004-11-11 | Romano Deghenghi | Implants for non-radioactive brachytherapy of hormonal-insensitive cancers |
EP2860292B1 (en) | 2003-05-08 | 2020-07-22 | Tepha, Inc. | Polyhydroxyalkanoate medical textiles and fibers |
DE202004009060U1 (en) | 2003-05-16 | 2004-08-12 | Blue Membranes Gmbh | Biocompatible coated medical implants |
ZA200509063B (en) | 2003-05-30 | 2007-03-28 | Titan Pharmaceuticals Inc | Impiantable polymeric device for sustained release of nalmefene |
EP1628693A1 (en) | 2003-06-04 | 2006-03-01 | Inion Ltd. | Biodegradable implant and method for manufacturing one |
US20040253293A1 (en) | 2003-06-16 | 2004-12-16 | Afshin Shafiee | Rate controlled release of a pharmaceutical agent in a biodegradable device |
ITMI20031302A1 (en) | 2003-06-26 | 2004-12-27 | Mediolanum Pharmaceuticals Ltd | USE OF ETHANOL AS A PLASTICIZER TO PREPARE SUBCUTANEOUS IMPLANTS CONTAINING THERMALABLE ACTIVE PRINCIPLES DISPERSED IN A PLGA MATRIX. |
ES2291893T3 (en) | 2003-06-26 | 2008-03-01 | Mediolanum Pharmaceuticals Limited | SUBCUTANEOUS IMPLANTS WITH LIMITED INITIAL RELEASE OF THE ACTIVE AND SUBSEQUENT PRINCIPLE LINEARLY VARIABLE LONG RELEASE OF THE SAME. |
US7220433B2 (en) | 2003-06-27 | 2007-05-22 | Ethicon, Inc. | Compositions for parenteral administration and sustained-release of therapeutic agents |
FI20045223A (en) | 2004-06-15 | 2005-12-16 | Bioretec Oy | A multifunctional biodegradable composite and a surgical implant comprising said composite |
US9114199B2 (en) | 2003-07-31 | 2015-08-25 | Boston Scientific Scimed, Inc. | Implantable or insertable medical devices containing acrylic copolymer for controlled delivery of therapeutic agent |
US7357940B2 (en) | 2003-07-31 | 2008-04-15 | Boston Scientific Scimed, Inc. | Implantable or insertable medical devices containing graft copolymer for controlled delivery of therapeutic agents |
US7914805B2 (en) | 2003-07-31 | 2011-03-29 | Boston Scientific Scimed, Inc. | Implantable or insertable medical devices containing radiation-treated polymer for improved delivery of therapeutic agent |
US8870814B2 (en) | 2003-07-31 | 2014-10-28 | Boston Scientific Scimed, Inc. | Implantable or insertable medical devices containing silicone copolymer for controlled delivery of therapeutic agent |
US20060240071A1 (en) | 2003-07-31 | 2006-10-26 | Sidney Lerner | Non-hormonal vaginal contraceptive |
US7169405B2 (en) | 2003-08-06 | 2007-01-30 | Warsaw Orthopedic, Inc. | Methods and devices for the treatment of intervertebral discs |
US20050037047A1 (en) | 2003-08-11 | 2005-02-17 | Young-Ho Song | Medical devices comprising spray dried microparticles |
US8529625B2 (en) | 2003-08-22 | 2013-09-10 | Smith & Nephew, Inc. | Tissue repair and replacement |
EP2462958A3 (en) | 2003-09-23 | 2012-09-19 | Orthocon Inc. | Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects |
WO2005039668A2 (en) | 2003-10-21 | 2005-05-06 | Boiarski Anthony A | Implantable drug delivery device for sustained release of therapeutic agent |
US7435256B2 (en) | 2003-11-06 | 2008-10-14 | Boston Scientific Scimed, Inc. | Method and apparatus for controlled delivery of active substance |
CA2536242A1 (en) | 2003-11-20 | 2005-06-09 | Angiotech International Ag | Implantable sensors and implantable pumps and anti-scarring agents |
US20050208095A1 (en) | 2003-11-20 | 2005-09-22 | Angiotech International Ag | Polymer compositions and methods for their use |
US20050249776A1 (en) | 2003-12-19 | 2005-11-10 | Chen Chao C | Coated aneurysmal repair device |
US8747881B2 (en) | 2003-12-19 | 2014-06-10 | Cordis Corporation | Intraluminal medical devices in combination with therapeutic agents |
EP1711159B1 (en) | 2003-12-30 | 2013-03-20 | Durect Corporation | Solid implants containing a block copolymer for controlled release of a gnrh compound |
US8329203B2 (en) | 2004-01-12 | 2012-12-11 | The Trustees Of The University Of Pennsylvania | Drug-containing implants and methods of use thereof |
US7303758B2 (en) | 2004-01-20 | 2007-12-04 | Cordis Corporation | Local vascular delivery of mycophenolic acid in combination with rapamycin to prevent restenosis following vascular injury |
US20050181015A1 (en) | 2004-02-12 | 2005-08-18 | Sheng-Ping (Samuel) Zhong | Layered silicate nanoparticles for controlled delivery of therapeutic agents from medical articles |
US7806924B2 (en) | 2004-02-18 | 2010-10-05 | Cordis Corporation | Implantable structures for local vascular delivery of cladribine in combination with rapamycin for restenosis |
US20050181047A1 (en) | 2004-02-18 | 2005-08-18 | Jaime Romero | Compositions and methods for timed release of water-soluble nutritional supplements |
US8828416B2 (en) | 2004-03-09 | 2014-09-09 | Cordis Corporation | Local vascular delivery of topotecan in combination with rapamycin to prevent restenosis following vascular injury |
US7695731B2 (en) | 2004-03-22 | 2010-04-13 | Cordis Corporation | Local vascular delivery of etoposide in combination with rapamycin to prevent restenosis following vascular injury |
US7034050B2 (en) | 2004-04-28 | 2006-04-25 | Romano Deghenghi | Pseudopeptides growth hormone secretagogues |
US8425929B2 (en) | 2004-04-30 | 2013-04-23 | Allergan, Inc. | Sustained release intraocular implants and methods for preventing retinal dysfunction |
US20050244465A1 (en) | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Drug delivery systems and methods for treatment of an eye |
US8685435B2 (en) | 2004-04-30 | 2014-04-01 | Allergan, Inc. | Extended release biodegradable ocular implants |
US20070059336A1 (en) | 2004-04-30 | 2007-03-15 | Allergan, Inc. | Anti-angiogenic sustained release intraocular implants and related methods |
US8119154B2 (en) | 2004-04-30 | 2012-02-21 | Allergan, Inc. | Sustained release intraocular implants and related methods |
US20050244469A1 (en) | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Extended therapeutic effect ocular implant treatments |
US20050244461A1 (en) | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Controlled release drug delivery systems and methods for treatment of an eye |
WO2006002399A2 (en) | 2004-06-24 | 2006-01-05 | Surmodics, Inc. | Biodegradable implantable medical devices, methods and systems |
WO2006002498A2 (en) | 2004-07-05 | 2006-01-12 | Ziscoat N.V. | Biocompatible coating of medical devices comprising molecular sieves |
EP1629844B2 (en) | 2004-07-13 | 2012-04-18 | Bayer Schering Pharma Oy | A longterm delivery system with controlled initial burst |
US7713539B2 (en) | 2004-07-19 | 2010-05-11 | Boston Scientific Scimed, Inc. | Medical devices containing radiation resistant block copolymer |
US7771740B2 (en) | 2004-07-19 | 2010-08-10 | Boston Scientific Scimed, Inc. | Medical devices containing copolymers with graft copolymer endblocks for drug delivery |
PT1781264E (en) | 2004-08-04 | 2013-10-16 | Evonik Corp | Methods for manufacturing delivery devices and devices thereof |
ES2395154T3 (en) | 2004-08-13 | 2013-02-08 | Mast Biosurgery Ag | Surgical prosthesis with biodegradable and non-biodegradable regions |
US20060039946A1 (en) | 2004-08-20 | 2006-02-23 | Medtronic Inc. | Drug eluting medical device |
US20060051390A1 (en) | 2004-09-03 | 2006-03-09 | Schwarz Marlene C | Medical devices having self-forming rate-controlling barrier for drug release |
EP3173072A1 (en) | 2004-10-01 | 2017-05-31 | Ramscor, Inc. | Conveniently implantable sustained release drug compositions |
WO2006041942A2 (en) | 2004-10-04 | 2006-04-20 | Qlt Usa, Inc. | Ocular delivery of polymeric delivery formulations |
US20060093643A1 (en) | 2004-11-04 | 2006-05-04 | Stenzel Eric B | Medical device for delivering therapeutic agents over different time periods |
CA2589761A1 (en) | 2004-12-07 | 2006-06-15 | Surmodics, Inc. | Coatings with crystallized active agent(s) and methods |
US20080254086A1 (en) | 2004-12-23 | 2008-10-16 | Brown James E | Controlled Release Compositions |
US20060198868A1 (en) | 2005-01-05 | 2006-09-07 | Dewitt David M | Biodegradable coating compositions comprising blends |
US20060147491A1 (en) | 2005-01-05 | 2006-07-06 | Dewitt David M | Biodegradable coating compositions including multiple layers |
US7988987B2 (en) | 2005-01-25 | 2011-08-02 | Boston Scientific Scimed, Inc. | Medical devices containing crazed polymeric release regions for drug delivery |
US8075906B2 (en) | 2005-02-01 | 2011-12-13 | Boston Scientific Scimed, Inc. | Medical devices having polymeric regions with copolymers containing hydrocarbon and heteroatom-containing monomeric species |
US20060171980A1 (en) | 2005-02-01 | 2006-08-03 | Helmus Michael N | Implantable or insertable medical devices having optimal surface energy |
US8663639B2 (en) * | 2005-02-09 | 2014-03-04 | Santen Pharmaceutical Co., Ltd. | Formulations for treating ocular diseases and conditions |
US20060177480A1 (en) | 2005-02-10 | 2006-08-10 | Hsing-Wen Sung | Drug-eluting biodegradable stent |
US20060204548A1 (en) | 2005-03-01 | 2006-09-14 | Allergan, Inc. | Microimplants for ocular administration |
JP5178506B2 (en) | 2005-03-14 | 2013-04-10 | バイオベンション ホールディングス リミテッド | Methods related to drug delivery compositions |
US7857856B2 (en) | 2005-03-15 | 2010-12-28 | Warsaw Ortho Pedic, Inc. | Composite spinal nucleus implant with water absorption and swelling capabilities |
US7517914B2 (en) | 2005-04-04 | 2009-04-14 | Boston Scientificscimed, Inc. | Controlled degradation materials for therapeutic agent delivery |
EP1868661A1 (en) | 2005-04-08 | 2007-12-26 | SurModics, Inc. | Sustained release implants for subretinal delivery |
US20060257448A1 (en) | 2005-05-10 | 2006-11-16 | The University Of Zurich | Resorbable polymer composition, implant and method of making implant |
US20070009564A1 (en) | 2005-06-22 | 2007-01-11 | Mcclain James B | Drug/polymer composite materials and methods of making the same |
US20070016163A1 (en) | 2005-06-28 | 2007-01-18 | Microchips, Inc. | Medical and dental implant devices for controlled drug delivery |
US8722074B2 (en) | 2005-07-19 | 2014-05-13 | Boston Scientific Scimed, Inc. | Medical devices containing radiation resistant polymers |
US20070048350A1 (en) | 2005-08-31 | 2007-03-01 | Robert Falotico | Antithrombotic coating for drug eluting medical devices |
US20070053952A1 (en) | 2005-09-07 | 2007-03-08 | Medtronic Vascular, Inc. | Nitric oxide-releasing polymers derived from modified polymers |
CA2623239C (en) | 2005-09-22 | 2016-07-12 | Medivas, Llc | Solid polymer delivery compositions and methods for use thereof |
US8784860B2 (en) | 2005-10-27 | 2014-07-22 | Cordis Corporation | Local administration of a combination of rapamycin and cilostazol for the treatment of vascular disease |
US20070196423A1 (en) | 2005-11-21 | 2007-08-23 | Med Institute, Inc. | Implantable medical device coatings with biodegradable elastomer and releasable therapeutic agent |
US20070116736A1 (en) | 2005-11-23 | 2007-05-24 | Argentieri Dennis C | Local vascular delivery of PI3 kinase inhibitors alone or in combination with sirolimus to prevent restinosis following vascular injury |
WO2007078922A2 (en) | 2005-12-30 | 2007-07-12 | Neurotech Usa Inc. | Micronized device for the delivery of biologically active molecules and methods of use thereof |
US7910152B2 (en) | 2006-02-28 | 2011-03-22 | Advanced Cardiovascular Systems, Inc. | Poly(ester amide)-based drug delivery systems with controlled release rate and morphology |
EP1834636A1 (en) | 2006-03-08 | 2007-09-19 | Sahajanand Medical Technologies PVT. ltd | Compositions comprising porous articles and uses in implantable medical devices |
US20070224239A1 (en) | 2006-03-27 | 2007-09-27 | Niall Behan | Method of making a coated medical device |
DK2004172T3 (en) | 2006-03-31 | 2019-04-23 | Mati Therapeutics Inc | PHARMACEUTICAL ADMINISTRATION STRUCTURES AND COMPOSITIONS FOR NASOLACRIMAL SYSTEM |
WO2008105791A2 (en) | 2006-06-22 | 2008-09-04 | University Of South Florida | Collagen scaffolds, medical implants with same and methods of use |
US8802128B2 (en) | 2006-06-23 | 2014-08-12 | Allergan, Inc. | Steroid-containing sustained release intraocular implants and related methods |
US20070298073A1 (en) | 2006-06-23 | 2007-12-27 | Allergan, Inc. | Steroid-containing sustained release intraocular implants and related methods |
US7638344B2 (en) | 2006-06-28 | 2009-12-29 | Surmodics, Inc. | Active agent eluting matrices with particulates |
US7731987B2 (en) | 2006-07-13 | 2010-06-08 | Advanced Cardiovascular Systems, Inc. | Implantable medical device comprising a pro-healing poly(ester-amide) |
US8506984B2 (en) | 2006-07-26 | 2013-08-13 | Cordis Corporation | Therapeutic agent elution control process |
US20080057102A1 (en) | 2006-08-21 | 2008-03-06 | Wouter Roorda | Methods of manufacturing medical devices for controlled drug release |
US20080075753A1 (en) | 2006-09-25 | 2008-03-27 | Chappa Ralph A | Multi-layered coatings and methods for controlling elution of active agents |
KR20120102598A (en) | 2009-09-17 | 2012-09-18 | 에보닉 데구사 코포레이션 | Implant devices that differ by release profile and methods of making and using same |
RU2545865C2 (en) | 2009-09-22 | 2015-04-10 | Евоник Корпорейшн | Implanted devices with various versions of biologically active ingredient loading |
KR20120102606A (en) | 2009-09-22 | 2012-09-18 | 에보닉 데구사 코포레이션 | Implant devices for modulating bioactive agent release profiles |
-
2005
- 2005-08-03 PT PT58569054T patent/PT1781264E/en unknown
- 2005-08-03 CA CA2575988A patent/CA2575988C/en active Active
- 2005-08-03 EP EP12194311.2A patent/EP2594259A1/en not_active Withdrawn
- 2005-08-03 WO PCT/US2005/027477 patent/WO2006078320A2/en active Application Filing
- 2005-08-03 US US11/196,591 patent/US8541028B2/en active Active
- 2005-08-03 EP EP05856905.4A patent/EP1781264B1/en active Active
- 2005-08-03 ES ES05856905T patent/ES2432556T3/en active Active
- 2005-08-03 AU AU2005325213A patent/AU2005325213B2/en active Active
-
2007
- 2007-10-31 HK HK07111739.6A patent/HK1103362A1/en unknown
-
2013
- 2013-07-31 US US13/952,595 patent/US20140037707A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4450150A (en) * | 1973-05-17 | 1984-05-22 | Arthur D. Little, Inc. | Biodegradable, implantable drug delivery depots, and method for preparing and using the same |
US4612009A (en) * | 1984-06-19 | 1986-09-16 | Ceskoslovenska Akademie Ved | Biodegradable implant and a method for preparation thereof |
US5153002A (en) * | 1991-03-04 | 1992-10-06 | University Of Montreal | Biocompatible gradient controlled release implant |
WO1993017662A1 (en) * | 1992-03-02 | 1993-09-16 | Daratech Pty. Ltd. | Improved implants |
US20030161881A1 (en) * | 2001-12-18 | 2003-08-28 | Hansen Henrik Egesborg | Solid dose micro implant |
Non-Patent Citations (1)
Title |
---|
ICHIRO YAMAKAWA ET AL: "SUSTAINED RELEASE OF INSULIN BY DOUBLE-LAYERED IMPLANT USING POLY(D,L-LACTIC ACID)", JOURNAL OF PHARMACEUTICAL SCIENCES, AMERICAN PHARMACEUTICAL ASSOCIATION. WASHINGTON, US, vol. 79, no. 6, 1 June 1990 (1990-06-01), pages 505 - 509, XP000132665, ISSN: 0022-3549 * |
Also Published As
Publication number | Publication date |
---|---|
EP1781264A2 (en) | 2007-05-09 |
CA2575988A1 (en) | 2006-07-27 |
US20140037707A1 (en) | 2014-02-06 |
HK1103362A1 (en) | 2007-12-21 |
PT1781264E (en) | 2013-10-16 |
AU2005325213A1 (en) | 2006-07-27 |
WO2006078320A2 (en) | 2006-07-27 |
AU2005325213B2 (en) | 2010-10-07 |
CA2575988C (en) | 2014-02-18 |
US8541028B2 (en) | 2013-09-24 |
EP1781264B1 (en) | 2013-07-24 |
EP2594259A1 (en) | 2013-05-22 |
ES2432556T3 (en) | 2013-12-04 |
US20060029637A1 (en) | 2006-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006078320A3 (en) | Methods for manufacturing delivery devices and devices thereof | |
HK1222346A1 (en) | Devices, systems and methods for fluid delivery | |
WO2008076731A3 (en) | A coating of fast absorption or dissolution | |
WO2009152276A3 (en) | Photoacid generators and lithographic resists comprising the same | |
WO2006049942A3 (en) | Drug coated medical device with nucleating agents | |
WO2007133583A3 (en) | Zero-order modified release solid dosage forms | |
EP1784267A4 (en) | Stent and method for manufacturing the stent | |
WO2007145961A3 (en) | Microporous coating on medical devices | |
HK1128251A1 (en) | Fluid delivery devices, systems and methods | |
WO2008064111A3 (en) | Radiopaque medical devices | |
WO2009059129A3 (en) | Endoprosthesis with porous reservoir and non-polymer diffusion layer | |
EP1895992A4 (en) | Compressible gum based delivery systems for the release of ingredients | |
WO2007067398A3 (en) | Solventless method for forming a coating | |
WO2007067469A3 (en) | Method for expelling gas positioned between a substrate and a mold | |
WO2007067488A3 (en) | Method and system for double-sided patterning of substrates | |
EP2034929A4 (en) | Prosthetic heart valves, support structures and systems and methods for implanting the same | |
WO2006121669A3 (en) | Coating of medical devices with solids | |
WO2006133103A3 (en) | Reservoir for delivery of agents | |
EP1737377A4 (en) | Coated medical device and method for manufacturing the same | |
WO2005046745A3 (en) | Method and device for controlled delivery of active substance | |
TWI368320B (en) | Solid state imaging device, manufacturing method of the same, and substrate for solid state imaging device | |
EP2079410A4 (en) | Devices, systems and methods having mobile ferromagnetic structures | |
WO2008070269A3 (en) | Methods, software and systems for imaging | |
NL1028255A1 (en) | Polymer for upper anti-reflective coating, method of preparing it, and composition of an upper anti-reflective coating comprising the polymer. | |
EP1816671A4 (en) | Exposure method, device manufacturing method, and substrate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2575988 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005325213 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005856905 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2005325213 Country of ref document: AU Date of ref document: 20050803 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005325213 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2005856905 Country of ref document: EP |